CIBC Bancorp USA »

Alnylam Pharmaceuticals shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2026-03-31 $56M 169k 330.87
2025-09-30 $2.1M 4.7k 456.00